{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-008035","form_type":"8-K","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.342330+00:00","generated_at":"2026-05-18T06:36:26.115010+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zivo Bioscience raises $250k initial tranche in $2M convertible debt offering","bullets":["Issued $250k bridge promissory note with 10% annual interest, compounded annually; due after 2 years or upon $5M+ equity financing.","Note converts at lower of issuance price or 80% of qualified financing share price; prepayment allowed at 115% of principal.","Accompanying warrant to purchase 1,793 shares at issuance closing price, 5-year term, immediately exercisable.","Total offering up to $2M; proceeds for general operations; notes unsecured and junior to secured debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-008035","json":"https://secwatch.observer/filing/0001654954-25-008035.json","markdown":"https://secwatch.observer/filing/0001654954-25-008035.md","text":"https://secwatch.observer/filing/0001654954-25-008035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/0001654954-25-008035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/zivo_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:36:26.115010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b3d57d07f330ab826b6d9ec12727098bcad7ccd","claim":"Zivo Bioscience, Inc. incurred convertible notes of $250,000 with an accredited investor at 10% interest per annum maturing two years after the date of issuance.","evidence_excerpt":"On July 8, 2025, Zivo Bioscience, Inc. (the“Company”) issued a Bridge Promissory Note in the principal amount of $250,000 and accompanying warrant to purchase 1,793 shares","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/0001654954-25-008035-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$250,000"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Rate","value":"10% interest per annum"},{"label":"Maturity","value":"two years after the date of issuance"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}